Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock 
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake 
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook 
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers 
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half 
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook 
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth 
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue 
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs 
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow 
World game at war: why some European nations have threatened a World Cup boycott 
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth 
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring 
Muruzábal will head up content creation and direction, while Valentán has the responsibility of production management
LOS ANGELES and MEXICO CITY and MADRID, Spain, May 08, 2018 -- Dopamine, the new Grupo Salinas content company focused on the creation, development and production of stories for international platforms, reports that Spanish Script Doctor Amaya Muruzábal, and Mexican executive producer Gabriela Valentán have been appointed Chief Content Officer and Chief of Production, respectively.
Muruzábal is a specialist in managing large teams of script writers for international entertainment and fiction formats, particularly short series. In addition to experience as director of development for companies such as La Competencia TV and Señor Mono in Spain, she has also worked as Script Doctor for numerous international film directors.
Valentán is an independent Mexican producer with top participation and executive experience in fiction for Mexico and US Hispanic markets. Her work includes bio series, dramatized series and documentaries for Bravo Films, Canal Once, Argos, Lemon Studios, Discovery, HBO, Sony Entertainment Television, Telemundo and Televisa, among others.
Dopamine CEO Fidela Navarro commented: "For the first time in Mexico, we have talented women at two key executive positions in this type of company. Amaya and Gabriela have the experience, the methodology, the sensitivity, the freshness, the vision and the passion that new Mexican content for the world requires. They deserve a challenge like this because they put it all on the line for great content."
Amaya Muruzábal holds a degree in Journalism and a PhD in Audiovisual Communication from the University of Navarra. She has received numerous awards, including the Audiovisual Council of Catalonia in Research.
Gabriela Valentán studied Film and Video Management at the International School of Film and TV (EICTV) in San Antonio de los Baños, Cuba. She has a degree in Dramatic Literature and Theater from the National Autonomous University of Mexico.
About Dopamine
A Grupo Salinas audiovisual company focused on the creation, development and production of original content for global platforms, under any model of management, business and partnership.
It is a one-stop-shop that cultivates stories, works with top producers and has the financial capacity to be a unique proposal in the Americas.
Press contact
Miguel Angel Oliva - CMO
[email protected]
